Indeed in a study by Cai et al. an increased mRNA becomes evident in VCaP xenograft tumour bearing mice after long-term AA treatments, whereas only one in four xenografts had increased CYP17A1 expression in short term treatments with the drug (Cai et al. 2011). This evidence concerns the gene CYP17A1 and neoplasm.